Categories: News

NYSE Content Advisory: Pre-Market update + BLS Reveals First Look at Labor Market Since September

NEW YORK, Nov. 20, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Ashley Mastronardi delivers the pre-market update on November 20th

- Advertisement -
  • Stocks are higher Thursday morning as investors react to a wave of reports, including strong earnings from NVIDIA that lifted the S&P 500 and Dow.
  • Fresh September jobs data showed the U.S. added about 50,000 positions, while the BLS confirmed the October report won’t be released due to the government shutdown.
  • Fed minutes revealed division over the recent rate cut, with traders now pricing in just a 31% chance of another cut in December.


Opening Bell

Viking Acquisition (NYSE: VACI) celebrates its recent IPO

- Advertisement -


Closing Bell

Emerson Electric (NYSE: EMR) celebrates its 2025 investor conference

- Advertisement -


Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2828733/NYSE_Nov_20_Market_Update.mp4
Logo – https://mma.prnewswire.com/media/2581322/5635055/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–bls-reveals-first-look-at-labor-market-since-september-302621769.html

- Advertisement -

Recent Posts

CoreWeave Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against CoreWeave, Inc. – CRWV

NEW ORLEANS, Jan. 14, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds…

4 hours ago

Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference

Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong China market presenceNext-generation…

4 hours ago

Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split

NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed”…

4 hours ago

New site in Lommel, Belgium: Aqua free successfully completes set-up phase with ISO 9001 certification

Lommel / Hamburg, 01/15/2026 – Aqua free, a leading provider of innovative drinking-water hygiene solutions, has…

4 hours ago